Deciphera Pharmaceuticals Inc Quick Ratio (DCPH) starting from the first quarter 2024 to first quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Deciphera Pharmaceuticals Inc   (NASDAQ: DCPH)

Deciphera Pharmaceuticals Inc 's Quick Ratio

DCPH's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Current Liabilities decreased faster than Deciphera Pharmaceuticals Inc 's Cash & cash equivalent, this led to improvement in Deciphera Pharmaceuticals Inc 's Quick Ratio to 3.41, Quick Ratio remained below Deciphera Pharmaceuticals Inc average.

Within Major Pharmaceutical Preparations industry 115 other companies have achieved higher Quick Ratio than Deciphera Pharmaceuticals Inc in first quarter 2024. While Quick Ratio total ranking in the first quarter 2024 has deteriorated compared to the prior quarter from 26 to 477.

Explain Quick Ratio?
How much Cash & cash equivalents DCPH´s has?
What are DCPH´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DCPH Quick Ratio (Mar 31 2024)
Q1		 (Dec 31 2023)
Q4		 (Sep 30 2023)
Q3		 (Jun 30 2023)
Q2		 (Mar 31 2023)
Q1
Y / Y Current Liabilities Change -0.94 % 16.26 % 23.74 % 8.71 % -3.73 %
Y / Y Cash & cash equivalent Change -31.63 % -5.63 % -6.99 % -14.36 % 55.38 %
Quick Ratio MRQ 3.41 3.16 3.79 4.23 4.95
DCPH's Total Ranking # 477 # 26 # 28 # 428 # 42
Seq. Current Liabilities Change -17.48 % 8.17 % 15.18 % -3.65 % -3.15 %
Seq. Cash & cash equivalent Change -11 % -9.69 % 3.14 % -17.53 % 22.85 %



Quick Ratio first quarter 2024 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 116
Healthcare Sector # 210
Overall Market # 477


Quick Ratio Statistics
High Average Low
18.36 6.28 0.7
(Jun 30 2018)   (Mar 31 2019)




Financial Statements
Deciphera Pharmaceuticals Inc 's Current Liabilities $ 80 Millions Visit DCPH's Balance sheet
Deciphera Pharmaceuticals Inc 's Cash & cash equivalent $ 273 Millions Visit DCPH's Balance sheet
Source of DCPH's Sales Visit DCPH's Sales by Geography


Cumulative Deciphera Pharmaceuticals Inc 's Quick Ratio

DCPH's Quick Ratio for the trailling 12 Months

DCPH Quick Ratio

 (Mar 31 2024)
12 Months		 (Dec 31 2023)
12 Months		 (Sep 30 2023)
12 Months		 (Jun 30 2023)
12 Months		 (Mar 31 2023)
12 Months
Y / Y Current Liabilities TTM Growth 11.76 % 10.88 % 2.23 % -3.31 % -2.84 %
Y / Y Cash & cash equivalent TTM Growth -15.29 % 3.25 % 7.77 % 11.68 % 14.98 %
Quick Ratio TTM 3.63 3.98 4.2 4.51 4.78
Total Ranking TTM # 3426 # 447 # 600 # 2046 # 3276
Seq. Current Liabilities TTM Growth -0.22 % 4.09 % 5.47 % 2.02 % -1.01 %
Seq. Cash & cash equivalent TTM Growth -9.19 % -1.31 % -1.8 % -3.74 % 10.69 %

Quick ratio ranking by company, industry and sector >> Back to DCPH Financial Strength Comparisons >> Go to Compare DCPH Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in DCPH's Current Liabilities to $79.86 millions, cumulative Quick Ratio to 3.63 below the DCPH average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 466 other companies have achieved higher Quick Ratio than Deciphera Pharmaceuticals Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2023 from 447 to 3426.

Explain Quick Ratio?
How much Cash & cash equivalents DCPH´s has?
What are DCPH´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 467
Healthcare Sector # 962
Within the Market # 3426


trailing twelve months Quick Ratio Statistics
High Average Low
14.44 7.82 3.49
(Dec 31 2018)   (Mar 31 2024)




Companies with similar Quick Ratio in the quarter ending Mar 31 2024, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2024 MRQ Cash & cash equivalentMar 31 2024 MRQ Current Liabilities
Rallybio Corporation  9.34 $ 94.175  Millions$ 10.086  Millions
Madrigal Pharmaceuticals Inc   9.31 $ 1,059.063  Millions$ 113.799  Millions
Bicycle Therapeutics Plc  9.23 $ 456.997  Millions$ 49.510  Millions
Adicet Bio Inc   9.15 $ 159.711  Millions$ 17.461  Millions
Forte Biosciences Inc   9.14 $ 30.444  Millions$ 3.332  Millions
Adial Pharmaceuticals Inc   9.09 $ 5.025  Millions$ 0.553  Millions
Cryoport inc   8.98 $ 439.849  Millions$ 48.982  Millions
Artelo Biosciences Inc   8.90 $ 6.414  Millions$ 0.721  Millions
Processa Pharmaceuticals Inc   8.83 $ 8.920  Millions$ 1.011  Millions
Cytokinetics Incorporated  8.76 $ 618.961  Millions$ 70.625  Millions
Syndax Pharmaceuticals Inc   8.72 $ 443.161  Millions$ 50.805  Millions
Centessa Pharmaceuticals Plc  8.39 $ 230.177  Millions$ 27.435  Millions
Coya Therapeutics Inc   8.33 $ 35.989  Millions$ 4.319  Millions
Bullfrog Ai Holdings Inc   8.30 $ 7.011  Millions$ 0.845  Millions
Opus Genetics Inc   8.15 $ 47.166  Millions$ 5.787  Millions
Lisata Therapeutics Inc   8.13 $ 43.349  Millions$ 5.333  Millions
Protagonist Therapeutics inc   8.08 $ 322.635  Millions$ 39.910  Millions
Xoma Royalty Corporation  8.06 $ 136.225  Millions$ 16.908  Millions
Tango Therapeutics Inc   8.03 $ 343.599  Millions$ 42.789  Millions
Kronos Bio Inc   7.99 $ 151.984  Millions$ 19.032  Millions
Calcimedica Inc   7.82 $ 25.710  Millions$ 3.287  Millions
Stoke Therapeutics Inc   7.76 $ 178.581  Millions$ 23.020  Millions
Repare Therapeutics Inc   7.75 $ 237.001  Millions$ 30.570  Millions
Generation Bio Co   7.75 $ 219.303  Millions$ 28.311  Millions
Igm Biosciences Inc   7.75 $ 293.768  Millions$ 37.930  Millions
Newamsterdam Pharma Company N v   7.73 $ 481.147  Millions$ 62.265  Millions
Silo Pharma Inc  7.72 $ 6.744  Millions$ 0.874  Millions
Phathom Pharmaceuticals Inc   7.41 $ 322.229  Millions$ 43.459  Millions
Ataibeckley Inc   7.41 $ 111.246  Millions$ 15.013  Millions
Galmed Pharmaceuticals Ltd   7.06 $ 15.331  Millions$ 2.173  Millions

Date modified: 2026-09-26T07:32:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.